Khan, S., & Durairaj, S. (2020). JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword. Int Arch Allergy Immunol.
Chicago-tyylinen lähdeviittausKhan, Sujoy, ja Senthil Durairaj. "JAK Inhibition With Methotrexate As Treatment for COVID-19 Is a Double-Edged Sword." Int Arch Allergy Immunol 2020.
MLA-viiteKhan, Sujoy, ja Senthil Durairaj. "JAK Inhibition With Methotrexate As Treatment for COVID-19 Is a Double-Edged Sword." Int Arch Allergy Immunol 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.